Authors: Li, WY Butler, JP Hale, JE McClure, DB Little, SP Czilli, DL Simmons, LK

Citation: Wy. Li et al., Suppression of an amyloid beta peptide-mediated calcium channel response by a secreted beta-amyloid precursor protein, NEUROSCIENC, 95(1), 2000, pp. 1-4

Authors: Lin, HS Rampersaud, AA Richett, ME Harper, RW Beavers, LS McClure, DB Gardner, AJ Eacho, PI Foxworthy, PS Gadski, RA

Citation: Hs. Lin et al., Synthesis and in vitro biological activity of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha-ol: A 24,25-dehydro analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol, STEROIDS, 64(3), 1999, pp. 217-227

Authors: Lin, HS Rampersaud, AA Beavers, LS McClure, DB Gardner, AJ Eacho, PI Foxworthy, PS Gadski, RA

Citation: Hs. Lin et al., Synthesis and in vitro biological activity of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha,12 alpha-diol, a 12 alpha-hydroxyl analog of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha-ol: The latter is a potent activator of the low-density lipoprotein receptor promoter, STEROIDS, 64(10), 1999, pp. 735-741

Authors: Bensch, WR Gadski, RA Bean, JS Beavers, LS Schmidt, RJ Perry, DN Murphy, AT McClure, DB Eacho, PI Breau, AP Archer, RA Kauffman, RF

Citation: Wr. Bensch et al., Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters, J PHARM EXP, 289(1), 1999, pp. 85-92